Controlled Drugs and Accountable Officer
The February 2026 edition of the NHSE Midlands CD Newsletter has now been published
Topics in this newsletter include:
- Faculty of Pain Medicine – Opioid aware – Recent update
- FP10 Prescription pad security audit
- Developing opioid safety across a system
- Switching between morphine and other opioids in palliative care
- Improving information supplied with Gabapentinoids (Pregabalin/Gabapentin), Benzodiazepines and Z-Drugs
- Discontinuation of Subutex® and Suboxone® tablets
- Learning from reg 28 – Patients who are prescribed opioids long-term
- Learning from incidents – Oxycodone and Oramorph
- Fake Private Prescriptions for Codeine
- Reminders
- Useful links
With effect from 1st August 2024, the NHS England Midlands Controlled Drugs Team will be using a single group (enquiries) e-mail account england.midlandscd@nhs.net
From 1 September 2024, the following arrangements will be in place for geographical CDAO cover
| West Midlands | East Midlands |
| Amit Dawda will be the CDAO for West Midlands and cover the following ICB areas: | Samantha Travis will be the CDAO for East Midlands and cover the following ICB areas: |
|
|
| Amit can be contacted on amit.dawda@nhs.net , or the West Midlands CD Team can be contacted via england.MidlandsCD@nhs.net | Sam can be contacted on Samantha.travis@nhs.net, or the East Midlands CD Team can be contacted via england.MidlandsCD@nhs.net |
Please could you share this newsletter with all relevant members of your team.
